Co-Diagnostics (CODX) Non-Current Deferred Tax Liability (2021 - 2023)
Historic Non-Current Deferred Tax Liability for Co-Diagnostics (CODX) over the last 3 years, with Q1 2023 value amounting to $203335.0.
- Co-Diagnostics' Non-Current Deferred Tax Liability fell 9653.53% to $203335.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $203335.0, marking a year-over-year decrease of 9653.53%. This contributed to the annual value of $2.4 million for FY2022, which is 13345.1% up from last year.
- Latest data reveals that Co-Diagnostics reported Non-Current Deferred Tax Liability of $203335.0 as of Q1 2023, which was down 9653.53% from $2.4 million recorded in Q4 2022.
- In the past 5 years, Co-Diagnostics' Non-Current Deferred Tax Liability registered a high of $5.9 million during Q1 2022, and its lowest value of -$7.2 million during Q4 2021.
- Moreover, its 3-year median value for Non-Current Deferred Tax Liability was $3.1 million (2022), whereas its average is $1.7 million.
- As far as peak fluctuations go, Co-Diagnostics' Non-Current Deferred Tax Liability soared by 13345.1% in 2022, and later crashed by 9653.53% in 2023.
- Quarter analysis of 3 years shows Co-Diagnostics' Non-Current Deferred Tax Liability stood at -$7.2 million in 2021, then soared by 133.45% to $2.4 million in 2022, then plummeted by 91.59% to $203335.0 in 2023.
- Its Non-Current Deferred Tax Liability stands at $203335.0 for Q1 2023, versus $2.4 million for Q4 2022 and $3.8 million for Q3 2022.